BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Jong LM, Jiskoot W, Swen JJ, Manson ML. Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics. Genes (Basel) 2020;11:E1509. [PMID: 33339226 DOI: 10.3390/genes11121509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lenoir C, Rollason V, Desmeules JA, Samer CF. Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature. Front Pharmacol 2021;12:733935. [PMID: 34867341 DOI: 10.3389/fphar.2021.733935] [Reference Citation Analysis]
2 Popovics P, Jain A, Skalitzky KO, Schroeder E, Ruetten H, Cadena M, Uchtmann KS, Vezina CM, Ricke WA. Osteopontin Deficiency Ameliorates Prostatic Fibrosis and Inflammation. Int J Mol Sci 2021;22:12461. [PMID: 34830342 DOI: 10.3390/ijms222212461] [Reference Citation Analysis]
3 Darakjian L, Deodhar M, Turgeon J, Michaud V. Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity. Int J Mol Sci 2021;22:4967. [PMID: 34067027 DOI: 10.3390/ijms22094967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vizzini A, Bonura A, La Paglia L, Fiannaca A, La Rosa M, Urso A, Mauro M, Vazzana M, Arizza V. Transcriptomic Analyses Reveal 2 and 4 Family Members of Cytochromes P450 (CYP) Involved in LPS Inflammatory Response in Pharynx of Ciona robusta. Int J Mol Sci 2021;22:11141. [PMID: 34681801 DOI: 10.3390/ijms222011141] [Reference Citation Analysis]
5 Zhou J, Yu Y, Ding L, Xu P, Wang Y. Matcha Green Tea Alleviates Non-Alcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating Lipid Metabolism and Inflammatory Responses. Nutrients 2021;13:1950. [PMID: 34204055 DOI: 10.3390/nu13061950] [Reference Citation Analysis]
6 White CM. Inflammation Suppresses Patients' Ability to Metabolize Cytochrome P450 Substrate Drugs. Ann Pharmacother 2021;:10600280211047864. [PMID: 34590872 DOI: 10.1177/10600280211047864] [Reference Citation Analysis]
7 Fujita I, Watanabe H, Ikegami K, Imafuku T, Ichimizu S, Chikamatsu M, Kobayashi K, Tanaka R, Yamada K, Maeda H, Maruyama T. Involvement of the Parathyroid Hormone-Related Protein on Changes in the CYP3A Expression in Cancer Cachexia. Mol Pharm 2021;18:4322-30. [PMID: 34734526 DOI: 10.1021/acs.molpharmaceut.1c00490] [Reference Citation Analysis]
8 Lenoir C, Terrier J, Gloor Y, Curtin F, Rollason V, Desmeules JA, Daali Y, Reny JL, Samer CF. Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail. Clin Pharmacol Ther 2021;110:1358-67. [PMID: 34473836 DOI: 10.1002/cpt.2412] [Reference Citation Analysis]
9 Li Z, Huang Y, Xu H, Li Z. Population pharmacokinetic and dose optimization of mycophenolic acid in children with anti-neutrophilic cytoplasmic antibody-associated nephritis. Eur J Clin Pharmacol. [DOI: 10.1007/s00228-021-03265-z] [Reference Citation Analysis]
10 Lenoir C, Rodieux F, Desmeules JA, Rollason V, Samer CF. Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review. Clin Pharmacokinet 2021;60:1537-55. [PMID: 34462878 DOI: 10.1007/s40262-021-01064-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Scott SA, Swen JJ. Pharmacogenomic Determinants of Interindividual Drug Response Variability: From Discovery to Implementation. Genes (Basel) 2021;12:393. [PMID: 33801919 DOI: 10.3390/genes12030393] [Reference Citation Analysis]
12 Lenoir C, Niederer A, Rollason V, Desmeules JA, Daali Y, Samer CF. Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics. CPT Pharmacometrics Syst Pharmacol 2021. [PMID: 34791831 DOI: 10.1002/psp4.12730] [Reference Citation Analysis]